Home          View all 329 MoA classes  

      

Enter a class name or drug name above to search the database.

CD38-directed Antibody Interactions [MoA] Mechanism of Action Drugs

NDC Number Brand Name Generic Name Labeler Dosage Form DEA Schedule Marketing Start Date
0024-0654 Sarclisa isatuximab Sanofi-Aventis U.S. LLC INJECTION, SOLUTION, CONCENTRATE 2020-03-02
0024-0656 Sarclisa isatuximab Sanofi-Aventis U.S. LLC INJECTION, SOLUTION, CONCENTRATE 2020-03-02
57894-502 DARZALEX Daratumumab Janssen Biotech, Inc. INJECTION, SOLUTION, CONCENTRATE 2015-11-16
57894-503 Darzalex Faspro daratumumab and hyaluronidase-fihj (human recombinant) Janssen Biotech, Inc. INJECTION 2020-05-01
57894-505 Darzalex IV Daratumumab Janssen Biotech, Inc. INJECTION, SOLUTION, CONCENTRATE 2021-10-15

 Mechanism of Action Classification 

Loading full table content...